Anavex
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
CEOChristopher U. Missling
CEOChristopher U. Missling
Employees42
Employees42
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2004
Founded2004
Employees42
Employees42
AVXL Key Statistics
Market cap804.83M
Market cap804.83M
Price-Earnings ratio-16.54
Price-Earnings ratio-16.54
Dividend yield—
Dividend yield—
Average volume1.17M
Average volume1.17M
High today$9.75
High today$9.75
Low today$9.33
Low today$9.33
Open price$9.52
Open price$9.52
Volume717.07K
Volume717.07K
52 Week high$14.44
52 Week high$14.44
52 Week low$5.03
52 Week low$5.03
AVXL News
TipRanks 4d
Promising Clinical Data and Market Potential Drive Buy Rating for Anavex Life SciencesAnavex Life Sciences, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy r...
TipRanks 5d
Anavex announces latest findings for blarcamesineAnavex (AVXL) Life Sciences announced the latest findings for blarcamesine, an oral small molecule for the potential treatment of early Alzheimer’s disease, AD....
People also own
Based on the portfolios of people who own AVXL. This list is generated using Robinhood data, and it’s not a recommendation.